A phase 2 study of idelalisib monotherapy in previously untreated patients >= 65 years with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) Meeting Abstract


Authors: Zelenetz, A.; Lamanna, N.; Kipps, T.; Coutre, S.; O'Brien, S.; Graves, J.; Ye, W.; Dubowy, R.; Flinn, I.
Abstract Title: A phase 2 study of idelalisib monotherapy in previously untreated patients >= 65 years with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
Meeting Title: XVI International Workshop on Chronic Lymphocytic Leukemia
Journal Title: Leukemia and Lymphoma
Volume: 56
Issue: Suppl. 1
Meeting Dates: 2015 Sep 6-9
Meeting Location: Sydney, Australia
ISSN: 1042-8194
Publisher: Taylor & Francis Group  
Date Published: 2015-09-01
Start Page: 97
End Page: 98
Language: English
ACCESSION: WOS:000368710200118
PROVIDER: wos
DOI: 10.3109/10428194.2015.1080893
Notes: Meeting Abstract: 117 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    767 Zelenetz
Related MSK Work